Viewing nowCombinationTelmisartan/amlodipine tablet 80/5mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Korea Union Pharmaceutical Co., Ltd.

MFDS item code 201605848 · Approved 2016.09.30 · Insurance code 665506860
Treatment of essential hypertension not controlled with monotherapy
For patients with essential hypertension, this medication can be used to manage blood pressure more effectively when blood pressure is not sufficiently controlled with amlodipine or telmisartan monotherapy. It helps reduce the risk of cardiovascular complications caused by elevated blood pressure and maintain a healthy blood pressure state. This medication is used for the treatment of hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to this medicine may be considered as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ○ Elderly patients: In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious problems for the fetus if used during pregnancy, especially in the second and third trimesters, and must be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with certain conditions or allergies, pregnant or breastfeeding women, or patients with severe liver or heart disease. Prior to use, patients must inform if they have special caution-required conditions, such as primary aldosteronism, valvular disease, liver impairment, gastrointestinal disease, renovascular hypertension, hypotension, dialysis patients, and elderly patients, and take it cautiously according to the physician's instructions. Common side effects may include dizziness and peripheral edema while taking this medication, and rare cases of fainting or severe allergic reactions may occur, so immediate consultation with healthcare personnel is necessary if abnormal symptoms appear. During treatment, regular monitoring of blood pressure, kidney function, and blood electrolyte levels is needed to ensure safe use of the medication. Drug interactions may occur if combined with other medications, so all medications being taken should be reported to healthcare personnel and instructions should be followed. This medication may cause drowsiness or dizziness during driving or operating machinery, so caution is needed. In case of overdose, serious hypotension or heart problems can occur, so the dosage must be strictly adhered to, and immediate emergency treatment should be sought in case of overdose. When storing, keep out of reach of children and maintain original packaging while avoiding moisture and direct sunlight.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and must be stored in a container that can block light. Additionally, it is recommended to store the medication at room temperature, ideally between 1 to 30 degrees Celsius.
A white and light gray, double convex, oval-shaped tablet.
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Korea Union Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.